Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06751537 · ClinicalTrials.gov registry record
Effectiveness of the WearME System for COPD Severity and Respiratory Function
A clinical trial of Chronic Obstructive Pulmonary Disease (COPD), sponsored by LASARRUS Clinic and Research Center.
- Recruiting
- Registry status
- 128
- Enrollment target
- 2
- Study locations
NCT06751537 is a study of Chronic Obstructive Pulmonary Disease (COPD) that is actively recruiting participants, run by LASARRUS Clinic and Research Center. The registered enrollment target is 128 participants, below the 648-participant average among 36 other Chronic Obstructive Pulmonary Disease (COPD) trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06751537, a study of Chronic Obstructive Pulmonary Disease (COPD), is actively recruiting participants, sponsored by LASARRUS Clinic and Research Center.
- RECRUITING
- Registry status
- 128 participants
- Enrollment target
- 2
- Study locations
Study Summary
This observational study evaluates the effectiveness of the WearME system in monitoring COPD severity and respiratory function by comparing its measurements to standard spirometry, capnography, and other clinical assessments in 128 COPD participants.
Conditions Studied
Study Locations (2)
Maryland
- Johns Hopkins - Baltimore
- TidalHealth - Salisbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2025-05-29 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06751537
The ClinicalTrials.gov registry entry for NCT06751537 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 648-participant average among 36 other Chronic Obstructive Pulmonary Disease (COPD) trials with a reported enrollment target (80% lower). The listed sponsor is LASARRUS Clinic and Research Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease (COPD) appearing as the primary indexed condition, and to 0 interventions.
NCT06751537 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06751537 about?
NCT06751537 is a clinical study titled "Effectiveness of the WearME System for COPD Severity and Respiratory Function". This observational study evaluates the effectiveness of the WearME system in monitoring COPD severity and respiratory function by comparing its measurements to standard spirometry, capnography, and other clinical assessments in 128 COPD participants.
What is the current status of trial NCT06751537?
This trial is currently recruiting. The enrollment target is 128 participants. The study started on 2025-05-29. Estimated completion is 2026-02-28.
What conditions does trial NCT06751537 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease (COPD).
Who is sponsoring clinical trial NCT06751537?
This trial is sponsored by LASARRUS Clinic and Research Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06751537 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease (COPD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RECRUITING · Phase 2
-
Multi-Center Clean Air Randomized Controlled Trial in COPD
RECRUITING · Phase 3
-
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RECRUITING · Phase 3
-
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.